QQ客服 官方微博 反馈留言

	Safety, pharmacokinetics and pharmacogenetics of a single ascending dose of pradefovir, a novel liver-targeting, anti-hepatitis B virus drug, in healthy Chinese subjects
	Ding, Yanhua; Zhang, Hong; Li, Xiaojiao; Li, Cuiyun; Chen, Guiling; Chen, Hong; Wu, Min; Niu, Junqi
刊名	HEPATOLOGY INTERNATIONAL
	2017
卷号	11期号:4
关键词	Pradefovir Hepatitis B Single ascending dose Tolerability Pharmacokinetics Pharmacogenetics
ISSN号	1936-0533
URL标识	查看原文
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/3539017
专题	吉林大学白求恩第一医院
推荐引用方式 GB/T 7714	Ding, Yanhua,Zhang, Hong,Li, Xiaojiao,et al. Safety, pharmacokinetics and pharmacogenetics of a single ascending dose of pradefovir, a novel liver-targeting, anti-hepatitis B virus drug, in healthy Chinese subjects[J]. HEPATOLOGY INTERNATIONAL,2017,11(4).
APA	Ding, Yanhua.,Zhang, Hong.,Li, Xiaojiao.,Li, Cuiyun.,Chen, Guiling.,...&Niu, Junqi.(2017).Safety, pharmacokinetics and pharmacogenetics of a single ascending dose of pradefovir, a novel liver-targeting, anti-hepatitis B virus drug, in healthy Chinese subjects.HEPATOLOGY INTERNATIONAL,11(4).
MLA	Ding, Yanhua,et al."Safety, pharmacokinetics and pharmacogenetics of a single ascending dose of pradefovir, a novel liver-targeting, anti-hepatitis B virus drug, in healthy Chinese subjects".HEPATOLOGY INTERNATIONAL 11.4(2017).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。